Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRacing: Perioperative Chemoimmunotherapy +/- Preoperative Chemoradiation in Gastric/GEJ Cancer
NCT05161572Phase 2Terminated
- Sponsor
- Fudan University
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Fudan University. Started Sep 2021; status: terminated.
02
Drugs
sintilimab
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT05161572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05161572.